🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To determine the effect of ezetimibe and simvastatin given together, and ez...
Status
Completed
Location
Multiple Locations
Start Date
2003-07
Trial ID
NCT00652301
Treatments Being Tested
The blood brain barrier (BBB) prevents some drugs from successfully reachin...
Status
Recruiting
Location
Columbia University Irving Medical Center
Start Date
2023-06-05
Trial ID
NCT05762419
Treatments Being Tested
This is a Phase II pilot study of chemotherapy and surgery for children wit...
Status
Completed
Location
St. Jude Children's Research Hospital
Start Date
1997-10
Trial ID
NCT00186849
The purpose of this study is: * To assess the effect of BIA 5 1058 400 mg ...
Status
Completed
Location
Simbec Research Ltd (Simbec)
Start Date
2018-06-11
Trial ID
NCT07173738
Treatments Being Tested
The purpose of this Phase 2 study is to find out what effect, good and/or b...
Status
Completed
Location
Memorial Sloan Kettering Basking Ridge
Start Date
2013-06-13
Trial ID
NCT01882816
Treatments Being Tested
Determine the effects of escalated dose of daunorubicin in induction treatm...
Status
Completed
Location
Asan Medical Center
Start Date
2001-08
Trial ID
NCT00474006
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as doxorubicin hydrochloride, b...
Status
Terminated
Location
Stanford Cancer Center
Start Date
2013-05-24
Trial ID
NCT01390584
This is a Phase 1, open-label, single-dose study of the safety, tolerabilit...
Status
Terminated
Location
University Hospital Cologne-Clinical Trial Center
Start Date
2017-05-29
Trial ID
NCT02808052
Treatments Being Tested
The primary purpose of this study is to evaluate the effect of the up-titra...
Status
Completed
Location
SGS Clinical Pharmacology Unit (located in ZNA Stuivenberg)
Start Date
2019-03-20
Trial ID
NCT03882255
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such as bevacizumab, can block tumor grow...
Status
Unknown
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2006-07
Trial ID
NCT00436709